mp:VDraft3.0.0 consolidatie medicatiegegevensMGR addendum: verschil tussen versies

Uit informatiestandaarden
Naar navigatie springen Naar zoeken springen
← Oudere bewerkingNieuwere bewerking →
Tim Schuller (overleg | bijdragen)
Write
2.859 bewerkingen
Geen bewerkingssamenvatting
Tim Schuller (overleg | bijdragen)
Write
2.859 bewerkingen
Geen bewerkingssamenvatting
Regel 1: Regel 1:
__NUMBEREDHEADINGS__
__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens MP9 3.0: addendum inhoudelijke gegevens test}}
{{DISPLAYTITLE:Beschikbaarstellen en sturen MP9 3.0 - Consolidatie: addendum inhoudelijke gegevens test}}


=Addenda voor inhoudelijke gegevens=
=Addenda voor inhoudelijke gegevens=
==Patiënt L. van de XXX_Meijsz==
==Patiënt C. XXX_Dijk==
<section begin=XXX_Meijsz />
<section begin=XXX_Dijk />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 17: Regel 18:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|colspan="3"|Initialen
|style="background-color: white;"|L.
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Geslachtsnaam
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Meijsz
|style="background-color: white;"|XXX_Dijk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Adresgegevens
|style="background-color: white;"|Knolweg 1003 9999ZA Apeldoorn Apeldoorn 157 Nederland 3 Woon-/verblijfadres
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900821 [BSN]
|style="background-color: white;"|999900456 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|colspan="4"|Geboortedatum
|style="background-color: white;"|27 okt 1985
|style="background-color: white;"|20 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Meijsz /><section begin=ALLMBHS_XXX_Meijsz /><section begin=MBH_MBH_300_hybride_voorschrift />
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_gestopt />
====Medicamenteuze behandeling MBH_300_hybride_voorschrift ====
====Medicamenteuze behandeling MBH_300_gestopt ====


{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_hybride_voorschrift_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestopt_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 51: Regel 49:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_hybride_voorschrift_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 12:10 uur
|style="background-color: white;"|T - 4 maanden om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 7 dagen
|style="background-color: white;"|T + 5 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 72: Regel 70:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Hannie_Huiske|Zorgverlener: Hannie_Huiske]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '16020' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 85: Regel 83:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, 1 maal per dag 2 stuks, Oraal
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_hybride_voorschrift (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_hybride_voorschrift_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestopt_MA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 104: Regel 102:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_hybride_voorschrift_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 18:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="3"|Einddatum
|style="background-color: white;"|T - 1 dag om 12:10 uur
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Hannie_Huiske|Zorgverlener: Hannie_Huiske]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|14 stuks
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '16020' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_hybride_voorschrift_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_hybride_voorschrift (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_hybride_voorschrift /><section begin=MBH_MBH_300_hybride_generiekeTA />
|}
====Medicamenteuze behandeling MBH_300_hybride_generiekeTA ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak 16020
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestopt_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 148: Regel 168:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|16020 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 15:10 uur
|style="background-color: white;"|T - 4 maanden om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 7 dagen
|style="background-color: white;"|T + 5 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 170: Regel 190:
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 176: Regel 205:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, 1 maal per dag 2 stuks, Oraal
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 189: Regel 218:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|Vooraankondiging_PresciptionID (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_hybride_generiekeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_hybride_generiekeTA />
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestopt_TA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Hannie_Huiske" title="Intern ID = Hannie_Huiske">Zorgverlener Hannie_Huiske</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|000004449 (in identificerend systeem: UZI Personen)
|style="background-color: white;"|T - 10 dagen om 19:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|colspan="3"|Einddatum
|style="background-color: white;"|Hannie H. Huiske
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zorgaanbieder
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#huisartsencentrum_Huiske|Zorgaanbieder: huisartsencentrum_Huiske]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Apotheek De Gulle Gaper
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="huisartsencentrum_Huiske" title="Intern ID = huisartsencentrum_Huiske">Zorgaanbieder huisartsencentrum_Huiske</span>
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="3"|Omschrijving
|style="background-color: white;"|00003336 (in identificerend systeem: URA)
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="3"|Toedieningsweg
|style="background-color: white;"|huisartsencentrum Huiske
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afdeling specialisme
|colspan="3"|Doseerinstructie
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|1 maal per dag 1 stuk
|}<section end=ALLMBHS_XXX_Meijsz />
==Patiënt B. XXX_Blik==
<section begin=XXX_Blik />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Naamgegevens
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|colspan="3"|Identificatie
|style="background-color: white;"|B.
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Geslachtsnaam
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|colspan="3"|Identificatie
|style="background-color: white;"|XXX_Blik
|style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|colspan="4"|MBH identificatie
|style="background-color: white;"|999900389 [BSN]
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}<section end=MBH_MBH_300_gestopt /><section begin=MBH_MBH_300_gewijzigd />
|colspan="4"|Geboortedatum
====Medicamenteuze behandeling MBH_300_gewijzigd ====
|style="background-color: white;"|13 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Blik /><section begin=ALLMBHS_XXX_Blik /><section begin=MBH_MBH_300_QA1 />
====Medicamenteuze behandeling MBH_300_QA1 ====


{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_QA1_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 289: Regel 306:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|style="background-color: white;"|T - 21 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 310: Regel 324:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 323: Regel 337:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_QA1_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 342: Regel 356:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|style="background-color: white;"|T - 2 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Ingangsdatum
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|rowspan="2"|
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Zorgverlener
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_QA1_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_QA1_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 384: Regel 416:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|style="background-color: white;"|T - 2 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 421: Regel 453:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 434: Regel 466:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_QA1_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 447: Regel 479:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|style="background-color: white;"|T - 21 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 458: Regel 498:
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA1_VV
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_QA1_MGB
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 485: Regel 539:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 10:04:23 uur
|style="background-color: white;"|T - 2 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 535: Regel 573:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie toedieningsafspraak
|colspan="5"|Relatie toedieningsafspraak
Regel 548: Regel 593:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA1 /><section begin=MBH_MBH_300_QA2 />
|}
====Medicamenteuze behandeling MBH_300_QA2 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_QA2_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 563: Regel 606:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 08:04 uur
|style="background-color: white;"|T - 2 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 72 dagen
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 597: Regel 646:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal,  
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_QA2_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 100 dagen om 08:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|300 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_QA2_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}<section end=MBH_MBH_300_gewijzigd /><section begin=MBH_MBH_300_gewijzigddoorander />
====Medicamenteuze behandeling MBH_300_gewijzigddoorander ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_QA2_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_eigen
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 658: Regel 681:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 09:04 uur
|style="background-color: white;"|T - 60 dagen om 08:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 72 dagen
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 695: Regel 715:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_QA2_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_wijzigingdoorander
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 721: Regel 734:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 09:04 uur
|style="background-color: white;"|T - 3 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|300 ml
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|rowspan="4"|
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|colspan="3"|Omschrijving
|style="background-color: white;"|MBH_300_QA2_VV
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Toedieningsweg
|style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatiegebruik MBH_300_QA2_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|MBH_300_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 68 dagen om 12:13:55 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksperiode
|colspan="5"|Relatie medicatieafspraak
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgverlener
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|colspan="4"|MBH identificatie
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|colspan="5"|Auteur is zorgaanbieder
|}
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 millimeter, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 millimeter
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA2 /><section begin=MBH_MBH_300_QA3 />
====Medicamenteuze behandeling MBH_300_QA3 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_QA3_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_techstakendoorander
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 841: Regel 797:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:10 uur
|style="background-color: white;"|T - 3 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 11 dagen
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 865: Regel 824:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 875: Regel 834:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal,  
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_QA3_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA3_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 50 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|4000 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_QA3_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_QA3_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 936: Regel 860:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|style="background-color: white;"|T - 60 dagen om 09:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 11 dagen
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 960: Regel 884:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 973: Regel 897:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 986: Regel 910:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_QA3_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 999: Regel 923:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|style="background-color: white;"|T - 3 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Ingangsdatum
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|4000 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_300_QA3_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_QA3_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 11 dagen
|style="background-color: white;"|T + 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.087: Regel 960:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 1.100: Regel 973:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie toedieningsafspraak
|colspan="5"|Relatie toedieningsafspraak
Regel 1.107: Regel 980:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA3 /><section begin=MBH_MBH_300_QA4 />
|}
====Medicamenteuze behandeling MBH_300_QA4 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_QA4_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.122: Regel 993:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|style="background-color: white;"|T - 3 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 19 dagen
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.156: Regel 1.033:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_QA4_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_zv
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.175: Regel 1.066:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA4_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|style="background-color: white;"|T - 3 dagen om 08:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|rowspan="3"|
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Ingangsdatum
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Einddatum
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_QA4_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_QA4_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="5"|Informant
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Informant is patient
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.254: Regel 1.120:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
Regel 1.267: Regel 1.133:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_QA4_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_pat
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.280: Regel 1.146:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|style="background-color: white;"|T om 08:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_300_QA4_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_QA4_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|colspan="4"|Gebruik indicator
Regel 1.330: Regel 1.158:
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T - 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 19 dagen
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 1.347: Regel 1.175:
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Informant
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.372: Regel 1.193:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 1.378: Regel 1.199:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 1.385: Regel 1.206:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA4 /><section begin=MBH_MBH_300_QA5 />
|}<section end=MBH_MBH_300_gewijzigddoorander /><section begin=MBH_MBH_300_onderbroken />
====Medicamenteuze behandeling MBH_300_QA5 ====
====Medicamenteuze behandeling MBH_300_onderbroken ====


{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_QA5_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.400: Regel 1.221:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:15 uur
|style="background-color: white;"|T - 153 dagen om 08:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Einddatum
|style="background-color: white;"|7 dagen
|style="background-color: white;"|T + 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 1.421: Regel 1.242:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.434: Regel 1.255:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_QA5_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA_onderbreken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA5_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:15 uur
|style="background-color: white;"|T - 100 dagen om 18:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|56 stuks
|style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_QA5_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_QA5_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.494: Regel 1.340:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:15 uur
|style="background-color: white;"|T - 153 dagen om 09:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Einddatum
|style="background-color: white;"|7 dagen
|style="background-color: white;"|T + 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 1.518: Regel 1.364:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.531: Regel 1.377:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 1.544: Regel 1.390:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_QA5_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA_onderbreken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.557: Regel 1.403:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:15 uur
|style="background-color: white;"|T - 100 dagen om 19:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 1.568: Regel 1.428:
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|56 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|rowspan="4"|
|style="background-color: white;"|MBH_300_QA5_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Omschrijving
|style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal,
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_QA5_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="3"|Toedieningsweg
|style="background-color: white;"|MBH_300_QA5_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="3"|Doseerinstructie
|style="background-color: white;"|T - 43 dagen om 08:00 uur
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|rowspan="2"|
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|colspan="3"|Identificatie
|style="background-color: white;"|Ja
|style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="5"|Relatie toedieningsafspraak
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Identificatie
|style="background-color: white;"|T - 50 dagen
|style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="4"|MBH identificatie
|style="background-color: white;"|7 dagen
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}<section end=MBH_MBH_300_onderbroken /><section begin=MBH_MBH_300_andermans1 />
|colspan="5"|Voorschrijver
====Medicamenteuze behandeling MBH_300_andermans1 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_andermans1_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|T - 10 dagen om 18:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Informant
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|colspan="3"|Einddatum
|style="background-color: white;"|Ja
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.652: Regel 1.512:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA5 /><section begin=MBH_MBH_300_QA6 />
|}
====Medicamenteuze behandeling MBH_300_QA6 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_QA6_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_andermans1_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.680: Regel 1.531:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_andermans1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 08:18 uur
|style="background-color: white;"|T - 10 dagen om 18:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 1 dag
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.714: Regel 1.568:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_QA6_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_zv
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.733: Regel 1.594:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA6_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_andermans1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 5 dagen om 08:18 uur
|style="background-color: white;"|T om 08:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|rowspan="3"|
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Ingangsdatum
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Einddatum
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_QA6_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_QA6_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 09:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="5"|Informant
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Informant is patient
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.812: Regel 1.648:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 1.825: Regel 1.661:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_QA6_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_pat
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.838: Regel 1.674:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_andermans1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 5 dagen om 09:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_300_QA6_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_QA6_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA6_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:59:59 uur
|style="background-color: white;"|T om 18:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|colspan="4"|Gebruik indicator
Regel 1.888: Regel 1.686:
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 1 dag
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 1.903: Regel 1.701:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Informant
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 1.930: Regel 1.721:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 1.936: Regel 1.727:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 1.943: Regel 1.734:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA6 /><section begin=MBH_MBH_300_QA7 />
|}<section end=MBH_MBH_300_andermans1 /><section begin=MBH_MBH_300_andermans2 />
====Medicamenteuze behandeling MBH_300_QA7 ====
====Medicamenteuze behandeling MBH_300_andermans2 ====


{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_QA7_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_andermans2_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 1.958: Regel 1.749:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA7_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_andermans2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 30 dagen om 10:11 uur
|style="background-color: white;"|T - 159 dagen om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, gedurende 2 weken''
|style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|style="background-color: white;"|T - 159 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Gebruiksduur
|style="background-color: white;"|2 weken
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, gedurende 2 weken, eerst gedurende 4 dagen 1 maal per dag om 18:00 3 stuks, dan gedurende 6 dagen 1 maal per dag om 18:00 2 stuks, dan gedurende 4 dagen 1 maal per dag om 18:00 3 stuks, Oraal
|style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag om 18:00 3 stuks
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag om 18:00 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 4 dagen 1 maal per dag om 18:00 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|gemeten INR waarde: 2,3
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA7_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA7 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA7 /><section begin=MBH_MBH_300_QA8 />
|}
====Medicamenteuze behandeling MBH_300_QA8 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_QA8_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_andermans2_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.029: Regel 1.802:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA8_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_andermans2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 40 dagen om 11:33 uur
|style="background-color: white;"|T - 159 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 40 dagen, gedurende 1 week''
|style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 40 dagen
|style="background-color: white;"|T - 159 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 40 dagen, gedurende 1 week, cyclus van 3 dagen: steeds eerst gedurende 2 dagen 1 maal per dag om 18:00 3 stuks, dan gedurende 1 dag 1 maal per dag om 18:00 2 stuks, Oraal
|style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag om 18:00 3 stuks
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag om 18:00 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Herhaalperiode cyclisch schema
|style="background-color: white;"|3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|gemeten INR waarde: 2,8
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 2.085: Regel 1.852:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA8_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA8 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA8 /><section begin=MBH_MBH_300_QA9 />
|}<section end=MBH_MBH_300_andermans2 /><section begin=MBH_MBH_300_geannuleerd />
====Medicamenteuze behandeling MBH_300_QA9 ====
====Medicamenteuze behandeling MBH_300_geannuleerd ====


{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_QA9_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.100: Regel 1.867:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA9_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 15 dagen om 14:44 uur
|style="background-color: white;"|T - 2 dagen om 18:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 15 dagen, gedurende 10 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 15 dagen
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 15 dagen, gedurende 10 dagen, eerst gedurende 8 dagen 1 maal per dag 1 stuk, dan gedurende 2 dagen 1 maal per dag 0 stuks, Oraal,
|style="background-color: white;"|Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 8 dagen 1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 0 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|gemeten INR waarde: 2,1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA9_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA9 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA9 /><section begin=MBH_MBH_300_QA10 />
|}
====Medicamenteuze behandeling MBH_300_QA10 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_QA10_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA_annuleren
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.171: Regel 1.917:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA10_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 13:55 uur
|style="background-color: white;"|T - 1 dag om 15:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, gedurende 4 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 5 dagen om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|4 dagen
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENPRCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 2.205: Regel 1.957:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag om 18:00 1 stuk, Oraal
|style="background-color: white;"|Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard ')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 4 dagen 1 maal per dag om 18:00 1 stuk
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|gemeten INR waarde: 2,5
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 2.221: Regel 1.970:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA10_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA10 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA10 /><section begin=MBH_MBH_300_QA11 />
|}
====Medicamenteuze behandeling MBH_300_QA11 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_QA11_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.236: Regel 1.983:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA11_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 10:44 uur
|style="background-color: white;"|T - 2 dagen om 19:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 8 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|8 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 8 dagen, eerst gedurende 5 dagen 1 maal per dag 4 stuks, dan gedurende 3 dagen 1 maal per dag 3 stuks, Oraal
|style="background-color: white;"|Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 5 dagen 1 maal per dag 4 stuks
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|gemeten INR waarde: 2,2
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 2.289: Regel 2.030:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA11_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA11 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA11 /><section begin=MBH_MBH_300_QA12 />
|}
====Medicamenteuze behandeling MBH_300_QA12 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_QA12_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA_annuleren
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.304: Regel 2.043:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_QA12_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_geannuleerd_TA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 74 dagen om 09:11 uur
|style="background-color: white;"|T - 1 dag om 16:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 74 dagen, tot en met T - 61 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 74 dagen
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 61 dagen
|style="background-color: white;"|T + 5 dagen om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Auteur
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak reden wijzigen of staken
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 74 dagen, tot en met T - 61 dagen, cyclus van 7 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 5 stuks, dan gedurende 5 dagen 1 maal per dag 3 stuks, Oraal
|style="background-color: white;"|Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 5 stuks
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|rowspan="2"|
|style="background-color: white;"|dan gedurende 5 dagen 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Herhaalperiode cyclisch schema
|colspan="3"|Identificatie
|style="background-color: white;"|7 dagen
|style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|gemeten INR waarde: 2,7
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_QA12_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_QA12 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_QA12 />
|}<section end=MBH_MBH_300_geannuleerd /><section begin=MBH_MBH_300_toekomstig />
====Medicamenteuze behandeling MBH_300_toekomstig ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_toekomstig_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|colspan="3"|Ingangsdatum
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|colspan="3"|Einddatum
|style="background-color: white;"|Peter van  Pulver
|style="background-color: white;"|T + 51 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zorgaanbieder
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen)
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|rowspan="4"|
|style="background-color: white;"|Tanja de Bakker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|colspan="3"|Omschrijving
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|colspan="3"|Doseerinstructie
|style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]]
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_toekomstig_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="4"|Identificatie
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|style="background-color: white;"|MBH_300_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|style="background-color: white;"|T - 1 dag om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="3"|Ingangsdatum
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="3"|Einddatum
|style="background-color: white;"|Apotheek De Gulle Gaper
|style="background-color: white;"|T + 51 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span>
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|11112222 (in identificerend systeem: URA)
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|Trombosedienst Ons Dorp
|style="background-color: white;"|DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afdeling specialisme
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK')
|}<section end=ALLMBHS_XXX_Blik />
==Patiënt R. van XXX_Sonnenberg==
<section begin=XXX_Sonnenberg />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Naamgegevens
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|colspan="3"|Toedieningsweg
|style="background-color: white;"|R.
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Geslachtsnaam
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|colspan="3"|Identificatie
|style="background-color: white;"|van
|style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|colspan="4"|MBH identificatie
|style="background-color: white;"|XXX_Sonnenberg
|style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}<section end=MBH_MBH_300_toekomstig /><section begin=MBH_MBH_300_gestoptandermans />
|colspan="4"|Identificatienummer
====Medicamenteuze behandeling MBH_300_gestoptandermans ====
|style="background-color: white;"|999901084 [BSN]
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1985-11-20
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=XXX_Sonnenberg /><section begin=ALLMBHS_XXX_Sonnenberg /><section end=ALLMBHS_XXX_Sonnenberg />
==Patiënt C. XXX_Brugge==
<section begin=XXX_Brugge />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Brugge
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900419 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|16 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Brugge /><section begin=ALLMBHS_XXX_Brugge /><section begin=MBH_MBH_300_start_eind />
====Medicamenteuze behandeling MBH_300_start_eind ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_start_eind_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.534: Regel 2.239:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 11:20 uur
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|T + 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 2.555: Regel 2.260:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 2.568: Regel 2.273:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
Regel 2.577: Regel 2.282:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_start_eind_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 11:20 uur
|style="background-color: white;"|T - 10 dagen om 18:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 2.598: Regel 2.318:
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|5 stuks
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_start_eind_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_start_eind_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.628: Regel 2.358:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 12:20 uur
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|T + 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 2.649: Regel 2.379:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 2.665: Regel 2.395:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, Oraal
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
Regel 2.678: Regel 2.408:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_start_eind_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.691: Regel 2.421:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 12:20 uur
|style="background-color: white;"|T - 10 dagen om 19:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 2.701: Regel 2.445:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|5 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|rowspan="4"|
|style="background-color: white;"|MBH_300_start_eind_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}<section end=MBH_MBH_300_gestoptandermans /><section begin=MBH_MBH_300_gewijzigd_toekomst />
====Medicamenteuze behandeling MBH_300_gewijzigd_toekomst ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_start_eind_MGB
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.729: Regel 2.496:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 4 dagen om 10:59:59 uur
|style="background-color: white;"|T - 11 dagen om 08:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 2.773: Regel 2.517:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 2.786: Regel 2.527:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 stuk
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_start_eind_MGB_patient
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.812: Regel 2.546:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 4 dagen om 10:59:59 uur
|style="background-color: white;"|T - 1 dag om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 2.839: Regel 2.564:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Reden wijzigen of staken
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT')
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 2.862: Regel 2.580:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal
|style="background-color: white;"|Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 stuk
|style="background-color: white;"|1 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie toedieningsafspraak
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_start_eind /><section begin=MBH_MBH_300_start_duur />
|}
====Medicamenteuze behandeling MBH_300_start_duur ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_start_duur_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.890: Regel 2.606:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 11:30 uur
|style="background-color: white;"|T - 1 dag om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 1 dag om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|3 weken
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 2.911: Regel 2.630:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 2.924: Regel 2.643:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_start_duur_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 11:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_start_duur_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_start_duur_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 2.988: Regel 2.669:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 12:30 uur
|style="background-color: white;"|T - 11 dagen om 10:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 3.012: Regel 2.690:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 3.025: Regel 2.703:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 3.038: Regel 2.716:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_start_duur_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.051: Regel 2.729:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 12:30 uur
|style="background-color: white;"|T - 1 dag om 11:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 3.063: Regel 2.749:
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|colspan="4"|Toedieningsafspraak reden wijzigen of staken
|style="background-color: white;"|21 stuks
|style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|colspan="3"|Toedieningsweg
|style="background-color: white;"|MBH_300_start_duur_VV
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|2.16.840.1.113883.2.4.3.11.999.77.16076005.1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_start_duur_MGB
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.089: Regel 2.799:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 12:00 uur
|style="background-color: white;"|T - 1 dag om 11:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Einddatum
|style="background-color: white;"|3 weken
|style="background-color: white;"|T + 1 dag om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Toedieningsafspraak stop type
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Informant
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Ja
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 3.143: Regel 2.839:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 3.156: Regel 2.852:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_start_duur /><section begin=MBH_MBH_300_chronisch />
|}<section end=MBH_MBH_300_gewijzigd_toekomst /><section begin=MBH_MBH_300_gebruik />
====Medicamenteuze behandeling MBH_300_chronisch ====
====Medicamenteuze behandeling MBH_300_gebruik ====


{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_chronisch_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_gebruik_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.171: Regel 2.874:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Gebruik indicator
|style="background-color: white;"|T - 30 dagen om 11:32 uur
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Auteur is patient
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|rowspan="2"|
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Product naam
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|Paracetamol 500mg
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 3.202: Regel 2.912:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 2 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 3.211: Regel 2.921:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}<section end=MBH_MBH_300_gebruik />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_chronisch_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|MBH_300_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="3"|Specialisme
|style="background-color: white;"|T - 30 dagen om 11:32 uur
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Marcha_van_Partners" title="Intern ID = Marcha_van_Partners">Zorgverlener Marcha_van_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|21 stuks
|style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Naamgegevens
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|Marcha van  Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Specialisme
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Jan_van_Harten" title="Intern ID = Jan_van_Harten">Zorgverlener Jan_van_Harten</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|rowspan="7"|
|style="background-color: white;"|MBH_300_chronisch_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_chronisch_VV_extraVVbestaandeMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="3"|Naamgegevens
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|Jan van Harten
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="3"|Specialisme
|style="background-color: white;"|T - 10 dagen om 11:35 uur
|style="background-color: white;"|Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Ziekenhuis_het_Gele_Hart|Zorgaanbieder: Ziekenhuis_het_Gele_Hart]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|rowspan="3"|
|style="background-color: white;"|90 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Organisatie naam
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|colspan="3"|Organisatie naam
|style="background-color: white;"|MBH_300_chronisch_MA
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Adresgegevens
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}
|-style="vertical-align:top; background-color: #E3E3E3;;"   
{| class="wikitable" width="85%"
|colspan="5"|<span id="Huisartsenpraktijk_Itis" title="Intern ID = Huisartsenpraktijk_Itis">Zorgaanbieder Huisartsenpraktijk_Itis</span>
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_chronisch_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|rowspan="4"|
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|T - 30 dagen om 12:32 uur
|style="background-color: white;"|00005111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Itis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Adresgegevens
|style="background-color: white;"|T - 30 dagen
|style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Organisatie naam
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|Apotheek Jansen en Co
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|<span id="Ziekenhuis_het_Gele_Hart" title="Intern ID = Ziekenhuis_het_Gele_Hart">Zorgaanbieder Ziekenhuis_het_Gele_Hart</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|00004444 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Organisatie naam
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Ziekenhuis het Gele Hart
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Adresgegevens
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Organisatie type
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '2.16.840.1.113883.2.4.15.1060')
|colspan="3"|Identificatie
|}<section end=ALLMBHS_XXX_Dijk />
|style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
==Patiënt C. XXX_Dijk==
|-style="vertical-align:top; background-color: #E3E3E3;;"
<section begin=XXX_Dijk />
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_chronisch_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|rowspan="6"|
|style="background-color: white;"|MBH_300_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="3"|Naamgebruik
|style="background-color: white;"|T - 30 dagen om 12:32 uur
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="2"|Achternaam
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|XXX_Dijk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|colspan="4"|Identificatienummer
|style="background-color: white;"|21 stuks
|style="background-color: white;"|999900456 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geboortedatum
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|20 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geslacht
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_NieuweMA />
|colspan="4"|Geneesmiddel - generiekere code
====Medicamenteuze behandeling MBH_300_NieuweMA ====
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_300_chronisch_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_NieuweMA_start_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.403: Regel 3.097:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 12:35 uur
|style="background-color: white;"|T - 289 dagen om 11:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Ingangsdatum
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|colspan="3"|Zorgverlener
|style="background-color: white;"|90 stuks
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Toedieningsweg
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|colspan="3"|Doseerinstructie
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatiegebruik MBH_300_chronisch_MGB
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_NieuweMA_stop_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="5" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Medicatiegebruik datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 11:43:12 uur
|style="background-color: white;"|T - 70 dagen om 13:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruik indicator
|rowspan="3"|
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Volgens afspraak indicator
|colspan="3"|Ingangsdatum
|style="background-color: white;"|Ja
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Einddatum
|style="background-color: white;"|T - 71 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingangsdatum
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|T - 30 dagen
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="6"|Voorschrijver
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant is patient
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|Ja
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur is zorgaanbieder
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="6"|Relatie toedieningsafspraak
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_chronisch_MGB_patient
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_NieuweMA_nieuw_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.525: Regel 3.207:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 11:43:12 uur
|style="background-color: white;"|T - 30 dagen om 10:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
Regel 3.550: Regel 3.226:
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 3.579: Regel 3.242:
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatiegebruik MBH_300_chronisch_MGB_informant_Zorgverlener
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_start_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="5" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_MGB_informant_Zorgverlener (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Medicatiegebruik datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 11:43:12 uur
|style="background-color: white;"|T - 289 dagen om 11:31 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="6"|Voorschrijver
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgverlener
|colspan="3"|Ingangsdatum
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="6"|Informant
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|colspan="4"|Geneesmiddel - primaire code
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|colspan="5"|Auteur is zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="6"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|colspan="3"|Doseerinstructie
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="6"|Relatie toedieningsafspraak
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_chronisch /><section begin=MBH_MBH_300_start_duur2 />
|}
====Medicamenteuze behandeling MBH_300_start_duur2 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_start_duur2_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_stop_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.670: Regel 3.311:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_NieuweMA_stop_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 11:30 uur
|style="background-color: white;"|T - 25 dagen om 15:55 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 71 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|28 dagen
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak reden wijzigen of staken
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 3.711: Regel 3.358:
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|rowspan="2"|
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_start_duur2_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 60 dagen om 11:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|28 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_300_start_duur2_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_start_duur2_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_nieuw_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.765: Regel 3.384:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 12:30 uur
|style="background-color: white;"|T - 25 dagen om 15:57 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 3.789: Regel 3.405:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 3.815: Regel 3.428:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_start_duur2_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_NieuweMA_start_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.828: Regel 3.441:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_NieuweMA_start_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 60 dagen om 12:30 uur
|style="background-color: white;"|T - 289 dagen om 11:32 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Gebruik indicator
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|28 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_300_start_duur2_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_start_duur2_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_start_duur2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 55 dagen om 15:21:33 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 3.878: Regel 3.453:
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 3.910: Regel 3.482:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 3.926: Regel 3.498:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 3.933: Regel 3.505:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_start_duur2 /><section begin=MBH_MBH_300_dosis_stuks />
|}
====Medicamenteuze behandeling MBH_300_dosis_stuks ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_dosis_stuks_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_NieuweMA_nieuw_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 3.948: Regel 3.525:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 130 dagen om 11:35 uur
|style="background-color: white;"|T - 10 dagen om 13:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 130 dagen
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 101 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 3.970: Regel 3.550:
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Informant is patient
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 dosis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_dosis_stuks_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 130 dagen om 11:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Auteur
Regel 4.013: Regel 3.565:
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|1 stuk
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|colspan="3"|Doseerinstructie
|style="background-color: white;"|MBH_300_dosis_stuks_MA
|style="background-color: white;"|1 maal per dag 1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}<section end=MBH_MBH_300_NieuweMA />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_dosis_stuks_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|rowspan="7"|
|style="background-color: white;"|MBH_300_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|T - 130 dagen om 12:35 uur
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Specialisme
|style="background-color: white;"|T - 130 dagen
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 101 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|rowspan="3"|
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Organisatie naam
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Organisatie naam
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Adresgegevens
|style="background-color: white;"|2 maal per dag 1 dosis
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|}<section end=ALLMBHS_XXX_Dijk />
|colspan="5"|Relatie medicatieafspraak
==Patiënt C. XXX_Dijk==
|-style="vertical-align:top; background-color: #E3E3E3;;"
<section begin=XXX_Dijk />
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_dosis_stuks_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="3"|Initialen
|style="background-color: white;"|MBH_300_dosis_stuks_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="3"|Naamgebruik
|style="background-color: white;"|T - 130 dagen om 12:35 uur
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="2"|Achternaam
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|XXX_Dijk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|colspan="4"|Identificatienummer
|style="background-color: white;"|1 stuk
|style="background-color: white;"|999900456 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geboortedatum
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|20 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geslacht
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_OTCmedicatie />
|colspan="4"|Geneesmiddel - generiekere code
====Medicamenteuze behandeling MBH_300_OTCmedicatie ====
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_300_dosis_stuks_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_dosis_stuks_MGB
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_OTCmedicatie_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.144: Regel 3.696:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_dosis_stuks_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 07:59:59 uur
|style="background-color: white;"|T - 30 dagen om 10:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T - 16 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|rowspan="3"|
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|colspan="3"|Ingangsdatum
|style="background-color: white;"|Ja
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 16 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 4.177: Regel 3.720:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.187: Regel 3.730:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|2 maal per dag 1 dosis, inhalatie
|style="background-color: white;"|Vanaf T - 30 dagen, tot en met T - 16 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 dosis
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_dosis_stuks /><section begin=MBH_MBH_300_nieuweMBHobvTA />
|}
====Medicamenteuze behandeling MBH_300_nieuweMBHobvTA ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_nieuweMBHobvTA_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_OTCmedicatie_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.215: Regel 3.749:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 10:00 uur
|style="background-color: white;"|T - 28 dagen om 14:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T - 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|T - 14 dagen om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 4.239: Regel 3.773:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.252: Regel 3.786:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, Zo nodig 3 maal per dag 2 stuks, oraal
|style="background-color: white;"|Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 4.258: Regel 3.792:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|Zo nodig 3 maal per dag 2 stuks
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_nieuweMBHobvTA_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud1
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.271: Regel 3.812:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 10 dagen om 10:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_nieuweMBHobvTA_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 3 dagen om 16:00 uur
|style="background-color: white;"|T - 270 dagen om 16:03 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|colspan="4"|Gebruik indicator
Regel 4.315: Regel 3.821:
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur''
|style="background-color: #E3E3E3;;"|''Vanaf T - 280 dagen, tot en met T - 273 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen om 10:00 uur
|style="background-color: white;"|T - 280 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 3 dagen om 16:00 uur
|style="background-color: white;"|T - 273 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Auteur
Regel 4.329: Regel 3.842:
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|colspan="3"|Zorgverlener
|style="background-color: white;"|Ja
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL APOTEX TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '67903' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL TABLET 500MG (code = '2194' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.346: Regel 3.859:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen om 10:00 uur, tot en met T - 3 dagen om 16:00 uur, 3 maal per dag 2 stuks, oraal
|style="background-color: white;"|Vanaf T - 280 dagen, tot en met T - 273 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 4.352: Regel 3.865:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 2 stuks
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweMBHobvTA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweMBHobvTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_nieuweMBHobvTA /><section begin=MBH_MBH_300_WDS_start_duur />
|}
====Medicamenteuze behandeling MBH_300_WDS_start_duur ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_WDS_start_duur_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud2
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.374: Regel 3.878:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_WDS_start_duur_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 10 dagen om 11:30 uur
|style="background-color: white;"|T - 150 dagen om 11:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, gedurende 2 weken''
|style="background-color: #E3E3E3;;"|''Vanaf T - 155 dagen, tot en met T - 147 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|style="background-color: white;"|T - 155 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 147 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Informant is patient
|style="background-color: white;"|2 weken
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Auteur
Regel 4.398: Regel 3.912:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, gedurende 2 weken, eerst gedurende 1 dag 1 maal per dag 2 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 1 stuk, dan gedurende 6 dagen 1 maal per dag 3 stuks, Oraal
|style="background-color: white;"|Vanaf T - 155 dagen, tot en met T - 147 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 1 dag 1 maal per dag 2 stuks
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 4
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_WDS_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_WDS_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_WDS_start_duur /><section begin=MBH_ MBH_300_WDS_start_duur2 />
|}
====Medicamenteuze behandeling  MBH_300_WDS_start_duur2 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_WDS_start_duur2_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud3
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.445: Regel 3.944:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_WDS_start_duur2_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 29 dagen om 09:22 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Gebruik indicator
|style="background-color: white;"|T - 15 dagen om 11:30 uur
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 15 dagen, gedurende 13 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 80 dagen, tot en met T - 75 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 15 dagen
|style="background-color: white;"|T - 80 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Einddatum
|style="background-color: white;"|13 dagen
|style="background-color: white;"|T - 75 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.479: Regel 3.991:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 15 dagen, gedurende 13 dagen, gedurende 13 dagen 1 maal per dag 1 stuk, Oraal
|style="background-color: white;"|Vanaf T - 80 dagen, tot en met T - 75 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 13 dagen 1 maal per dag 1 stuk
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_WDS_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_WDS_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_ MBH_300_WDS_start_duur2 />
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_nieuw
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_nieuw (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|style="background-color: white;"|T - 16 dagen om 14:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Peter van  Pulver
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zorgaanbieder
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|colspan="3"|Einddatum
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Marcha_van_Partners" title="Intern ID = Marcha_van_Partners">Zorgverlener Marcha_van_Partners</span>
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|colspan="3"|Zorgverlener
|style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen)
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|rowspan="2"|
|style="background-color: white;"|Marcha van  Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|colspan="3"|Informant is patient
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zorgaanbieder
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span>
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|colspan="3"|Omschrijving
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen)
|style="background-color: white;"|Vanaf T - 28 dagen, tot en met T - 14 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Tanja de Bakker
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|colspan="3"|Doseerinstructie
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zorgaanbieder
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]]
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="3"|Identificatie
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|style="background-color: white;"|MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="4"|MBH identificatie
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_OTCmedicatie />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
Regel 4.587: Regel 4.129:
|style="background-color: white;"|Apotheek De Gulle Gaper
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Huisartsenpraktijk_Itis" title="Intern ID = Huisartsenpraktijk_Itis">Zorgaanbieder Huisartsenpraktijk_Itis</span>
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00005111 (in identificerend systeem: URA)
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Itis
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|}<section end=ALLMBHS_XXX_Dijk />
|colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span>
==Patiënt C. XXX_Dijk==
|-style="vertical-align:top; background-color: #E3E3E3;;"
<section begin=XXX_Dijk />
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11112222 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Trombosedienst Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afdeling specialisme
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp
|}<section end=ALLMBHS_XXX_Brugge />
==Patiënt M. XXX_Niesing==
<section begin=XXX_Niesing />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
Regel 4.630: Regel 4.156:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|colspan="3"|Initialen
|style="background-color: white;"|M.
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|colspan="3"|Naamgebruik
Regel 4.640: Regel 4.166:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Niesing
|style="background-color: white;"|XXX_Dijk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900845 [BSN]
|style="background-color: white;"|999900456 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|colspan="4"|Geboortedatum
|style="background-color: white;"|29 okt 1985
|style="background-color: white;"|20 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Niesing /><section begin=ALLMBHS_XXX_Niesing /><section begin=MBH_MBH_300_HPKvoorschrijven />
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_ToekomstigEnNieuweMA />
====Medicamenteuze behandeling MBH_300_HPKvoorschrijven ====
====Medicamenteuze behandeling MBH_300_ToekomstigEnNieuweMA ====


{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_HPKvoorschrijven_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_startMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.661: Regel 4.187:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 170 dagen om 13:00 uur
|style="background-color: white;"|T - 98 dagen om 15:11 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, gedurende 50 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 170 dagen
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Gebruiksduur
|style="background-color: white;"|T - 21 dagen
|style="background-color: white;"|50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 4.685: Regel 4.211:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.698: Regel 4.221:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|style="background-color: white;"|Vanaf T - 98 dagen, gedurende 50 dagen, 2 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_HPKvoorschrijven_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.717: Regel 4.240:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 170 dagen om 13:00 uur
|style="background-color: white;"|T - 70 dagen om 14:44 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 4.728: Regel 4.259:
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|150 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|rowspan="4"|
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|colspan="3"|Doseerinstructie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_HPKvoorschrijven_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_stopMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.762: Regel 4.290:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 170 dagen om 14:00 uur
|style="background-color: white;"|T - 63 dagen om 09:13 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, tot en met T - 63 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 170 dagen
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T - 21 dagen
|style="background-color: white;"|T - 63 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.799: Regel 4.327:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|style="background-color: white;"|Vanaf T - 98 dagen, tot en met T - 63 dagen, 2 maal per dag 2 stuks, oraal,  
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 4.812: Regel 4.340:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_HPKvoorschrijven_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_NieuwMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.825: Regel 4.353:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_NieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 170 dagen om 14:00 uur
|style="background-color: white;"|T - 63 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Einddatum
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|rowspan="2"|
|style="background-color: white;"|150 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Zorgverlener
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|rowspan="4"|
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Omschrijving
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|Vanaf T - 30 dagen, tot en met T + 9 dagen, gedurende 39 dagen 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|colspan="3"|Toedieningsweg
|style="background-color: white;"|MBH_300_HPKvoorschrijven_VV
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|gedurende 39 dagen 2 maal per dag 1 stuk
|}
|-style="vertical-align:top; background-color: #E3E3E3;;" 
{| class="wikitable" width="85%"
|colspan="5"|Relatie medicatieafspraak
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_HPKvoorschrijven_MGB
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_startTA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.863: Regel 4.407:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 22:08 uur
|style="background-color: white;"|T - 98 dagen om 15:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.920: Regel 4.441:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 4.926: Regel 4.447:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie toedieningsafspraak
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_HPKvoorschrijven_MGB_patient
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstTA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 4.946: Regel 4.467:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 22:08 uur
|style="background-color: white;"|T - 70 dagen om 14:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 4.996: Regel 4.501:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 5.002: Regel 4.507:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie toedieningsafspraak
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_HPKvoorschrijven /><section begin=MBH_MBH_300_ZINRvoorschrijven />
|}
====Medicamenteuze behandeling MBH_300_ZINRvoorschrijven ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ZINRvoorschrijven_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_startMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.024: Regel 4.527:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 13:05 uur
|style="background-color: white;"|T - 98 dagen om 15:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Zorgverlener
|style="background-color: white;"|T + 150 dagen
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 5.048: Regel 4.568:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 5.064: Regel 4.581:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
|style="background-color: white;"|Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_ZINRvoorschrijven_VV
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_ToekomstMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.083: Regel 4.614:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 13:05 uur
|style="background-color: white;"|T - 70 dagen om 14:50 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
Regel 5.094: Regel 4.653:
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|150 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Doseerinstructie
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Identificatie
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|rowspan="2"|
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|}
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_ToekomstigEnNieuweMA />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|rowspan="7"|
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|T om 14:05 uur
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Specialisme
|style="background-color: white;"|T
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 150 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|rowspan="3"|
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="3"|Organisatie naam
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Organisatie naam
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Adresgegevens
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|}<section end=ALLMBHS_XXX_Dijk />
|colspan="5"|Relatie medicatieafspraak
==Patiënt C. XXX_Dijk==
|-style="vertical-align:top; background-color: #E3E3E3;;"
<section begin=XXX_Dijk />
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|rowspan="6"|
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="3"|Naamgebruik
|style="background-color: white;"|T om 14:05 uur
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="2"|Achternaam
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|XXX_Dijk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|colspan="4"|Identificatienummer
|style="background-color: white;"|150 stuks
|style="background-color: white;"|999900456 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geboortedatum
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|style="background-color: white;"|20 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geslacht
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_nieuweToekomstigeMA />
|colspan="4"|Geneesmiddel - generiekere code
====Medicamenteuze behandeling MBH_300_nieuweToekomstigeMA ====
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_ZINRvoorschrijven_MGB
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_startMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.238: Regel 4.788:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 22:08 uur
|style="background-color: white;"|T - 20 dagen om 10:01 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Gebruiksduur
|style="background-color: white;"|T
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 5.282: Regel 4.812:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 5.298: Regel 4.822:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 5.304: Regel 4.828:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_ZINRvoorschrijven_MGB_patient
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_toekomstMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.324: Regel 4.841:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MGB_patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 22:08 uur
|style="background-color: white;"|T - 15 dagen om 13:26 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Gebruiksduur
|style="background-color: white;"|T
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Voorschrijver
Regel 5.352: Regel 4.863:
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="4"|Geneesmiddel - primaire code
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 5.377: Regel 4.875:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
Regel 5.383: Regel 4.881:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_ZINRvoorschrijven /><section begin=MBH_MBH_300_WDSmetHPK />
|}
====Medicamenteuze behandeling MBH_300_WDSmetHPK ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_WDSmetHPK_WDS
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_annuleerMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.405: Regel 4.894:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_WDSmetHPK_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_annuleerMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 3 dagen om 16:25 uur
|style="background-color: white;"|T - 5 dagen om 15:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, gedurende 7 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 3 dagen
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|colspan="3"|Gebruiksduur
|style="background-color: white;"|7 dagen
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 5.429: Regel 4.921:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|MARCOUMAR TABLET 3MG (code = '52477' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '1783' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENPROCOUMON TABLET 3MG (code = '6637' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 3 dagen, gedurende 7 dagen, eerst gedurende 3 dagen 1 maal per dag 0.5 stuk, dan gedurende 1 dag 1 maal per dag 0 stuks, dan gedurende 2 dagen 1 maal per dag 0.5 stuk, dan gedurende 1 dag 1 maal per dag 0 stuks, Oraal
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag 0.5 stuk
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 0.5 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 4
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 5.464: Regel 4.944:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_WDSmetHPK_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_WDSmetHPK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_WDSmetHPK />
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_nieuwTMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_nieuwTMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 15:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 4 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|rowspan="3"|
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|colspan="3"|Ingangsdatum
|style="background-color: white;"|Peter van  Pulver
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|colspan="3"|Gebruiksduur
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|style="background-color: white;"|4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Zorgaanbieder
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="3"|Omschrijving
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|colspan="3"|Doseerinstructie
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|style="background-color: white;"|gedurende 4 dagen 1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|colspan="3"|Identificatie
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|colspan="4"|MBH identificatie
|style="background-color: white;"|Apotheek De Gulle Gaper
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=ALLMBHS_XXX_Niesing />
|}
==Patiënt J. XXX_Bree==
<section begin=XXX_Bree />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_startTA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 10:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Naamgegevens
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|colspan="3"|Ingangsdatum
|style="background-color: white;"|J.
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Geslachtsnaam
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|XXX_Bree
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|999901588 [BSN]
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|2010-07-01
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|2
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|}<section end=XXX_Bree /><section begin=ALLMBHS_XXX_Bree /><section end=ALLMBHS_XXX_Bree />
==Patiënt M. XXX_Pherai==
<section begin=XXX_Pherai />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Naamgegevens
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|colspan="3"|Omschrijving
|style="background-color: white;"|M.
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|colspan="3"|Identificatie
|style="background-color: white;"|XXX_Pherai
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|colspan="4"|MBH identificatie
|style="background-color: white;"|999900870 [BSN]
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Pherai /><section begin=ALLMBHS_XXX_Pherai /><section begin=MBH_MBH_300_wdsmtd1 />
====Medicamenteuze behandeling MBH_300_wdsmtd1 ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_wdsmtd1_MA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_toekomstTA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.599: Regel 5.083:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|style="background-color: white;"|T - 15 dagen om 13:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Voorschrijver
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 5.630: Regel 5.120:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, Volgens schema trombosedienst, Oraal
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende instructie
|colspan="3"|Identificatie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_opstartschema
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_startMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.649: Regel 5.146:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|style="background-color: white;"|T - 20 dagen om 10:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 15 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
Regel 5.662: Regel 5.165:
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Gebruiksduur
|style="background-color: white;"|T - 15 dagen
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Auteur
Regel 5.673: Regel 5.190:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|rowspan="2"|
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|colspan="3"|Identificatie
|style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_trombosedienst
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_toekomstMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.712: Regel 5.236:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 15 dagen om 14:30 uur
|style="background-color: white;"|T - 15 dagen om 13:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 14 dagen
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Informant is patient
|style="background-color: white;"|T - 5 dagen
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Auteur
Regel 5.733: Regel 5.277:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 5 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Herhaalperiode cyclisch schema
|style="background-color: white;"|5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Relatie medicatieafspraak
Regel 5.768: Regel 5.306:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie wisselend doseerschema
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}<section end=MBH_MBH_300_nieuweToekomstigeMA />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_technischestop
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|rowspan="7"|
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_technischestop (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|T - 7 dagen om 10:30 uur
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Specialisme
|style="background-color: white;"|T - 14 dagen
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 7 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal,
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Organisatie naam
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|rowspan="4"|
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 3
|colspan="3"|Organisatie naam
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Herhaalperiode cyclisch schema
|colspan="3"|Adresgegevens
|style="background-color: white;"|5 dagen
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=ALLMBHS_XXX_Dijk />
==Patiënt C. XXX_Dijk==
<section begin=XXX_Dijk />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Initialen
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie wisselend doseerschema
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="2"|Achternaam
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|XXX_Dijk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900456 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|Geslacht
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_stopMA_zonder_referentie />
====Medicamenteuze behandeling MBH_300_stopMA_zonder_referentie ====
 
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_wdsmtd1_WDS_verhoging
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_stopMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.867: Regel 5.413:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Wisselend doseerschema datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 7 dagen om 10:30 uur
|style="background-color: white;"|T - 5 dagen om 13:55 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen, tot en met T + 3 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 6 dagen
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|colspan="3"|Einddatum
|style="background-color: white;"|T + 3 dagen
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 6 dagen, tot en met T + 3 dagen, cyclus van 5 dagen: steeds eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks, dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk, oraal
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 1
|colspan="3"|Doseerinstructie
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie 2
|colspan="4"|MBH identificatie
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_startMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Herhaalperiode cyclisch schema
|colspan="4"|Identificatie
|style="background-color: white;"|5 dagen
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|Dosering aangepast i.v.m. te lage INR waarde.
|style="background-color: white;"|T - 5 dagen om 13:57 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie medicatieafspraak
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Ingangsdatum
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Einddatum
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"|T + 2 dagen
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Verstrekkingsverzoek MBH_300_wdsmtd1_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Auteur
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
Regel 5.957: Regel 5.491:
|colspan="3"|Zorgverlener
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Beoogd verstrekker
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 1 maal per dag 1.5 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|colspan="3"|Doseerinstructie
|style="background-color: white;"|MBH_300_wdsmtd1_MA
|style="background-color: white;"|1 maal per dag 1.5 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_wdsmtd1_TA
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_toekomstMA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 5.988: Regel 5.522:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|style="background-color: white;"|T - 5 dagen om 14:03 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="4"|Gebruiksperiode
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen''
|style="background-color: #E3E3E3;;"|''Vanaf T + 3 dagen, gedurende 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|style="background-color: white;"|T + 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Gebruiksinstructie
|colspan="5"|Gebruiksinstructie
Regel 6.022: Regel 5.556:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, Volgens schema trombosedienst, Oraal
|style="background-color: white;"|Vanaf T + 3 dagen, gedurende 3 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende instructie
|colspan="3"|Doseerinstructie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieverstrekking MBH_300_wdsmtd1_MVE
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_stopMA_zonder_referentie_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 6.048: Regel 5.575:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|style="background-color: white;"|T - 14 dagen om 15:14 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Verstrekker
|colspan="5"|Verstrekker
Regel 6.059: Regel 5.597:
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|rowspan="4"|
|style="background-color: white;"|MBH_300_wdsmtd1_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="3"|Omschrijving
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatietoediening MBH_300_wdsmtd1_MTD1
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|colspan="3"|Toedieningsweg
|style="background-color: white;"|MBH_300_wdsmtd1_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toedienings datum tijd
|colspan="3"|Doseerinstructie
|style="background-color: white;"|T - 20 dagen om 20:30 uur
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afgesproken datum tijd
|colspan="4"|MBH identificatie
|style="background-color: white;"|T - 20 dagen om 20:00 uur
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Toegediende hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aantal
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Afgesproken hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aantal
|style="background-color: white;"|2
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toedieningsweg
|style="background-color: white;"|ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Toediener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Mantelzorger
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Contactpersoon
|style="background-color: white;"|Zie [[#Toos_de_Bakker|Contactpersoon: Toos_de_Bakker]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatietoediening MBH_300_wdsmtd1_MTD2
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_stopMA_zonder_referentie_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
Regel 6.155: Regel 5.631:
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedienings datum tijd
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 19 dagen om 20:00 uur
|style="background-color: white;"|T - 14 dagen om 15:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken datum tijd
|colspan="4"|Gebruik indicator
|style="background-color: white;"|T - 19 dagen om 20:00 uur
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Toegediende hoeveelheid
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|colspan="3"|Ingangsdatum
|style="background-color: white;"|1
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|colspan="3"|Einddatum
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Afgesproken hoeveelheid
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|colspan="3"|Zorgverlener
|style="background-color: white;"|2
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Toediener
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Informant is patient
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]]
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatietoediening reden van afwijken
|colspan="3"|Zorgverlener
|style="background-color: white;"|toediening van medicatie geweigerd (code = '406149000' in codeSystem 'SNOMED CT')
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Relatie wisselend doseerschema
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
|}<section end=MBH_MBH_300_stopMA_zonder_referentie />
{| class="wikitable" width="85%"
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatietoediening MBH_300_wdsmtd1_MTD3
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|-style="background-color: #1F497D;; color: white; text-align:left;"  
|colspan="4" width="25%"| Gegevenselement
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|rowspan="7"|
|style="background-color: white;"|MBH_300_wdsmtd1_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedienings datum tijd
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|T - 17 dagen om 20:00 uur
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken datum tijd
|colspan="3"|Naamgegevens
|style="background-color: white;"|T - 17 dagen om 20:00 uur
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|colspan="3"|Specialisme
|style="background-color: white;"|Nee
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Toegediende hoeveelheid
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|1
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Afgesproken hoeveelheid
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|1
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|colspan="3"|Organisatie naam
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|-style="vertical-align:top; background-color: #E3E3E3;;"   
|colspan="5"|Toediener
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]]
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatietoediening reden van afwijken
|colspan="3"|Organisatie naam
|style="background-color: white;"|niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT')
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|colspan="3"|Adresgegevens
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|}<section end=ALLMBHS_XXX_Dijk />
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|Geprobeerd, maar niet gelukt met de tablet
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatietoediening MBH_300_wdsmtd1_MTD4
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedienings datum tijd
|style="background-color: white;"|T - 16 dagen om 20:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken datum tijd
|style="background-color: white;"|T - 16 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Toegediende hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|style="background-color: white;"|0
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Afgesproken hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Toediener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatietoediening reden van afwijken
|style="background-color: white;"|zorgafnemer niet beschikbaar om medicatie in ontvangst te nemen (code = '153241000146104' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_wdsmtd1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde


|-style="vertical-align:top; background-color: #E3E3E3;;" 
[[Categorie:Kwalificatie]]
|colspan="5"|<span id="Toos_de_Bakker" title="Intern ID = Toos_de_Bakker">Contactpersoon Toos_de_Bakker</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Toos de Bakker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Rol
|style="background-color: white;"|Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Tanja de Bakker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11112222 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Trombosedienst Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afdeling specialisme
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|: Kerkstraat  28 d 1332GH Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Thuiszorg_Om_en_Bij" title="Intern ID = Thuiszorg_Om_en_Bij">Zorgaanbieder Thuiszorg_Om_en_Bij</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11110000 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Thuiszorg Om en Bij
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie type
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060')
|}<section end=ALLMBHS_XXX_Pherai />
==Patiënt M. van de XXX_Roelofs==
<section begin=XXX_Roelofs />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1985-11-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=XXX_Roelofs /><section begin=ALLMBHS_XXX_Roelofs /><section end=ALLMBHS_XXX_Roelofs />
==Patiënt C. XXX_Dijk==
<section begin=XXX_Dijk />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900456 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Dijk /><section begin=ALLMBHS_XXX_Dijk /><section begin=MBH_MBH_300_gestopt />
====Medicamenteuze behandeling MBH_300_gestopt ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestopt_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 4 maanden om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 5 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestopt_MA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 18:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestopt_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 4 maanden om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 5 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 5 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestopt_TA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 19:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_gestopt /><section begin=MBH_MBH_300_gewijzigd />
====Medicamenteuze behandeling MBH_300_gewijzigd ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 21 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_MA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 21 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 2 dagen, 2 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_gewijzigd /><section begin=MBH_MBH_300_gewijzigddoorander />
====Medicamenteuze behandeling MBH_300_gewijzigddoorander ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_eigen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 08:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_wijzigingdoorander
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 3 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_techstakendoorander
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 3 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 09:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 3 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 3 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_zv
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 3 dagen om 08:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_pat
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 08:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T - 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 3 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_gewijzigddoorander /><section begin=MBH_MBH_300_onderbroken />
====Medicamenteuze behandeling MBH_300_onderbroken ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 153 dagen om 08:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA_onderbreken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 18:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 153 dagen om 09:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA_onderbreken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 19:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 153 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_onderbroken /><section begin=MBH_MBH_300_andermans1 />
====Medicamenteuze behandeling MBH_300_andermans1 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_andermans1_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 18:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_andermans1_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_andermans1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 18:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_zv
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_andermans1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 08:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_pat
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_andermans1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 18:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 9 dagen, tot en met T, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_andermans1 /><section begin=MBH_MBH_300_andermans2 />
====Medicamenteuze behandeling MBH_300_andermans2 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_andermans2_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_andermans2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 159 dagen om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 159 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Jan_van_Harten|Zorgverlener: Jan_van_Harten]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_andermans2_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_andermans2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 159 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 159 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_andermans2 /><section begin=MBH_MBH_300_gebruik />
====Medicamenteuze behandeling MBH_300_gebruik ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_gebruik_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Paracetamol 500mg
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 2 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_gebruik /><section begin=MBH_MBH_300_geannuleerd />
====Medicamenteuze behandeling MBH_300_geannuleerd ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 18:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA_annuleren
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 15:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 5 dagen om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard ')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 19:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA_annuleren
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_geannuleerd_TA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 16:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 5 dagen om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak reden wijzigen of staken
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_geannuleerd /><section begin=MBH_MBH_300_toekomstig />
====Medicamenteuze behandeling MBH_300_toekomstig ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_toekomstig_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 51 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_toekomstig_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 51 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_toekomstig /><section begin=MBH_MBH_300_gestoptandermans />
====Medicamenteuze behandeling MBH_300_gestoptandermans ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 18:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 19:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_gestoptandermans /><section begin=MBH_MBH_300_gewijzigd_toekomst />
====Medicamenteuze behandeling MBH_300_gewijzigd_toekomst ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 11 dagen om 08:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 1 dag om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Marcha_van_Partners|Zorgverlener: Marcha_van_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 11 dagen om 10:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_wijziging
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 11:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak reden wijzigen of staken
|style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|2.16.840.1.113883.2.4.3.11.999.77.16076005.1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 11:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 1 dag om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_gewijzigd_toekomst /><section begin=MBH_MBH_300_NieuweMA />
====Medicamenteuze behandeling MBH_300_NieuweMA ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_NieuweMA_start_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 289 dagen om 11:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_NieuweMA_stop_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 70 dagen om 13:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 71 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_NieuweMA_nieuw_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 30 dagen om 10:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_start_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 289 dagen om 11:31 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_stop_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_stop_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 25 dagen om 15:55 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 71 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak reden wijzigen of staken
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_nieuw_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 25 dagen om 15:57 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_NieuweMA_start_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 289 dagen om 11:32 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 289 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_NieuweMA_nieuw_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 10 dagen om 13:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_NieuweMA /><section begin=MBH_MBH_300_OTCmedicatie />
====Medicamenteuze behandeling MBH_300_OTCmedicatie ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_OTCmedicatie_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 30 dagen om 10:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T - 16 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 16 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, tot en met T - 16 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_OTCmedicatie_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 28 dagen om 14:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 14 dagen om 00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud1
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 270 dagen om 16:03 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 280 dagen, tot en met T - 273 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 280 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 273 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 280 dagen, tot en met T - 273 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud2
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 150 dagen om 11:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 155 dagen, tot en met T - 147 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 155 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 147 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 155 dagen, tot en met T - 147 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud3
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 29 dagen om 09:22 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 80 dagen, tot en met T - 75 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 80 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 75 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 80 dagen, tot en met T - 75 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_nieuw
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MGB_nieuw (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 16 dagen om 14:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 28 dagen, tot en met T - 14 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_OTCmedicatie /><section begin=MBH_MBH_300_ToekomstigEnNieuweMA />
====Medicamenteuze behandeling MBH_300_ToekomstigEnNieuweMA ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_startMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 98 dagen om 15:11 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, gedurende 50 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 98 dagen, gedurende 50 dagen, 2 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 70 dagen om 14:44 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_stopMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 63 dagen om 09:13 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, tot en met T - 63 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 63 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 98 dagen, tot en met T - 63 dagen, 2 maal per dag 2 stuks, oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_NieuwMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_NieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 63 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, tot en met T + 9 dagen, gedurende 39 dagen 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 39 dagen 2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_startTA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 98 dagen om 15:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstTA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 70 dagen om 14:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_startMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 98 dagen om 15:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 98 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_ToekomstMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 70 dagen om 14:50 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_ToekomstigEnNieuweMA /><section begin=MBH_MBH_300_nieuweToekomstigeMA />
====Medicamenteuze behandeling MBH_300_nieuweToekomstigeMA ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_startMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 10:01 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_toekomstMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 15 dagen om 13:26 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_annuleerMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_annuleerMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 15:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_nieuwTMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_nieuwTMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 15:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 4 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of staken
|style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 4 dagen 1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_startTA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 10:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_toekomstTA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 15 dagen om 13:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_startMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 20 dagen om 10:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_toekomstMGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 15 dagen om 13:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|1 week
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_nieuweToekomstigeMA /><section begin=MBH_MBH_300_stopMA_zonder_referentie />
====Medicamenteuze behandeling MBH_300_stopMA_zonder_referentie ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_stopMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 13:55 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak stop type
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, Oraal,
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_startMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 13:57 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 1 maal per dag 1.5 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1.5 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_toekomstMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 14:03 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 3 dagen, gedurende 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 3 dagen, gedurende 3 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_300_stopMA_zonder_referentie_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 14 dagen om 15:14 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatiegebruik MBH_300_stopMA_zonder_referentie_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 14 dagen om 15:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_300_stopMA_zonder_referentie />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Marcha_van_Partners" title="Intern ID = Marcha_van_Partners">Zorgverlener Marcha_van_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Marcha van  Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Itis|Zorgaanbieder: Huisartsenpraktijk_Itis]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Jan_van_Harten" title="Intern ID = Jan_van_Harten">Zorgverlener Jan_van_Harten</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Jan van Harten
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Ziekenhuis_het_Gele_Hart|Zorgaanbieder: Ziekenhuis_het_Gele_Hart]]
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Huisartsenpraktijk_Itis" title="Intern ID = Huisartsenpraktijk_Itis">Zorgaanbieder Huisartsenpraktijk_Itis</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00005111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Itis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek Jansen en Co
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|<span id="Ziekenhuis_het_Gele_Hart" title="Intern ID = Ziekenhuis_het_Gele_Hart">Zorgaanbieder Ziekenhuis_het_Gele_Hart</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00004444 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Ziekenhuis het Gele Hart
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie type
|style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '2.16.840.1.113883.2.4.15.1060')
|}<section end=ALLMBHS_XXX_Dijk />
==Patiënt H. XXX_Hoek==
<section begin=XXX_Hoek />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|H.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Hoek
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900638 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|5 nov 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Hoek /><section begin=ALLMBHS_XXX_Hoek /><section begin=MBH_MBH_300_contactepisode />
====Medicamenteuze behandeling MBH_300_contactepisode ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatieafspraak MBH_300_contactepisode_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie contact
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatienummer
|style="background-color: white;"|MBH_300_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709)
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Relatie zorgepisode
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatienummer
|style="background-color: white;"|MBH_300_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_300_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Wisselend doseerschema MBH_300_contactepisode_WDS_opstartschema
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

Versie van 21 jul 2023 10:39

__NUMBEREDHEADINGS__


1 Addenda voor inhoudelijke gegevens[bewerken]

1.1 Patiënt C. XXX_Dijk[bewerken]

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
Geslachtsnaam
Achternaam XXX_Dijk
Identificatienummer 999900456 [BSN]
Geboortedatum 20 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.1.1 Medicamenteuze behandeling MBH_300_gestopt[bewerken]

Medicatieafspraak MBH_300_gestopt_MA
Gegevenselement Waarde
Identificatie MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 4 maanden om 08:00 uur
Gebruiksperiode Vanaf T - 4 maanden, tot en met T + 5 maanden
Ingangsdatum T - 4 maanden
Einddatum T + 5 maanden
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gestopt_MA_staken
Gegevenselement Waarde
Identificatie MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 10 dagen om 18:00 uur
Gebruiksperiode Vanaf T - 4 maanden, tot en met T - 10 dagen
Ingangsdatum T - 4 maanden
Einddatum T - 10 dagen
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Reden wijzigen of staken geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gestopt_TA
Gegevenselement Waarde
Identificatie MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 4 maanden om 09:00 uur
Gebruiksperiode Vanaf T - 4 maanden, tot en met T + 5 maanden
Ingangsdatum T - 4 maanden
Einddatum T + 5 maanden
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 4 maanden, tot en met T + 5 maanden, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gestopt_TA_staken
Gegevenselement Waarde
Identificatie MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 10 dagen om 19:00 uur
Gebruiksperiode Vanaf T - 4 maanden, tot en met T - 10 dagen
Ingangsdatum T - 4 maanden
Einddatum T - 10 dagen
Toedieningsafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.2 Medicamenteuze behandeling MBH_300_gewijzigd[bewerken]

Medicatieafspraak MBH_300_gewijzigd_MA
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 21 dagen om 08:02 uur
Gebruiksperiode Vanaf T - 21 dagen
Ingangsdatum T - 21 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gewijzigd_MA_wijziging
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 2 dagen om 08:02 uur
Gebruiksperiode Vanaf T - 2 dagen
Ingangsdatum T - 2 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Reden wijzigen of staken gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 2 dagen, 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gewijzigd_MA_techstaken
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 2 dagen om 08:02 uur
Gebruiksperiode Vanaf T - 21 dagen, tot en met T - 3 dagen
Ingangsdatum T - 21 dagen
Einddatum T - 3 dagen
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigd_TA
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 21 dagen om 09:02 uur
Gebruiksperiode Vanaf T - 21 dagen
Ingangsdatum T - 21 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigd_TA_wijziging
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 2 dagen om 09:02 uur
Gebruiksperiode Vanaf T - 2 dagen
Ingangsdatum T - 2 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 2 dagen, 2 maal per dag 2 stuks, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigd_TA_techstaken
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 2 dagen om 09:02 uur
Gebruiksperiode Vanaf T - 21 dagen, tot en met T - 3 dagen
Ingangsdatum T - 21 dagen
Einddatum T - 3 dagen
Toedieningsafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.3 Medicamenteuze behandeling MBH_300_gewijzigddoorander[bewerken]

Medicatieafspraak MBH_300_gewijzigddoorander_MA_eigen
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 60 dagen om 08:05 uur
Gebruiksperiode Vanaf T - 60 dagen, tot en met T + 14 dagen
Ingangsdatum T - 60 dagen
Einddatum T + 14 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gewijzigddoorander_MA_wijzigingdoorander
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 3 dagen om 08:10 uur
Gebruiksperiode Vanaf T - 3 dagen, tot en met T + 30 dagen
Ingangsdatum T - 3 dagen
Einddatum T + 30 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Reden wijzigen of staken gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gewijzigddoorander_MA_techstakendoorander
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 3 dagen om 08:10 uur
Gebruiksperiode Vanaf T - 60 dagen, tot en met T - 4 dagen
Ingangsdatum T - 60 dagen
Einddatum T - 4 dagen
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigddoorander_TA
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 60 dagen om 09:05 uur
Gebruiksperiode Vanaf T - 60 dagen, tot en met T + 14 dagen
Ingangsdatum T - 60 dagen
Einddatum T + 14 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 60 dagen, tot en met T + 14 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigddoorander_TA_wijziging
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 3 dagen om 09:10 uur
Gebruiksperiode Vanaf T - 3 dagen, tot en met T + 30 dagen
Ingangsdatum T - 3 dagen
Einddatum T + 30 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 3 dagen, tot en met T + 30 dagen, 1 maal per dag 2 stuks, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigddoorander_TA_techstaken
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 3 dagen om 09:10 uur
Gebruiksperiode Vanaf T - 60 dagen, tot en met T - 4 dagen
Ingangsdatum T - 60 dagen
Einddatum T - 4 dagen
Toedieningsafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 60 dagen, tot en met T - 4 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_gewijzigddoorander_MGB_zv
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 3 dagen om 08:08 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 60 dagen, tot en met T - 3 dagen
Ingangsdatum T - 60 dagen
Einddatum T - 3 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 60 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_gewijzigddoorander_MGB_pat
Gegevenselement Waarde
Identificatie MBH_300_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T om 08:08 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 3 dagen, tot en met T - 1 dag
Ingangsdatum T - 3 dagen
Einddatum T - 1 dag
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Auteur
Auteur is patient Ja
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 3 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.4 Medicamenteuze behandeling MBH_300_onderbroken[bewerken]

Medicatieafspraak MBH_300_onderbroken_MA
Gegevenselement Waarde
Identificatie MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 153 dagen om 08:06 uur
Gebruiksperiode Vanaf T - 153 dagen, tot en met T + 20 dagen
Ingangsdatum T - 153 dagen
Einddatum T + 20 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_onderbroken_MA_onderbreken
Gegevenselement Waarde
Identificatie MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 100 dagen om 18:12 uur
Gebruiksperiode Vanaf T - 153 dagen, tot en met T - 100 dagen
Ingangsdatum T - 153 dagen
Einddatum T - 100 dagen
Medicatieafspraak stop type onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Reden wijzigen of staken verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_onderbroken_TA
Gegevenselement Waarde
Identificatie MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 153 dagen om 09:06 uur
Gebruiksperiode Vanaf T - 153 dagen, tot en met T + 20 dagen
Ingangsdatum T - 153 dagen
Einddatum T + 20 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 153 dagen, tot en met T + 20 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_onderbroken_TA_onderbreken
Gegevenselement Waarde
Identificatie MBH_300_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 100 dagen om 19:12 uur
Gebruiksperiode Vanaf T - 153 dagen, tot en met T - 100 dagen
Ingangsdatum T - 153 dagen
Einddatum T - 100 dagen
Toedieningsafspraak stop type onderbroken (code = '385655000' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 153 dagen, tot en met T - 100 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.5 Medicamenteuze behandeling MBH_300_andermans1[bewerken]

Medicatieafspraak MBH_300_andermans1_MA
Gegevenselement Waarde
Identificatie MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 10 dagen om 18:05 uur
Gebruiksperiode Vanaf T - 9 dagen, tot en met T + 15 dagen
Ingangsdatum T - 9 dagen
Einddatum T + 15 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Jan_van_Harten
Geneesmiddel - primaire code PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_andermans1_TA
Gegevenselement Waarde
Identificatie MBH_300_andermans1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 10 dagen om 18:45 uur
Gebruiksperiode Vanaf T - 9 dagen, tot en met T + 15 dagen
Ingangsdatum T - 9 dagen
Einddatum T + 15 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 9 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_andermans1_MGB_zv
Gegevenselement Waarde
Identificatie MBH_300_andermans1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T om 08:08 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 9 dagen, tot en met T
Ingangsdatum T - 9 dagen
Einddatum T
Voorschrijver
Zorgverlener Zie Zorgverlener: Jan_van_Harten
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Jan_van_Harten
Geneesmiddel - primaire code PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 9 dagen, tot en met T, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_andermans1_MGB_pat
Gegevenselement Waarde
Identificatie MBH_300_andermans1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T om 18:08 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 9 dagen, tot en met T
Ingangsdatum T - 9 dagen
Einddatum T
Voorschrijver
Zorgverlener Zie Zorgverlener: Jan_van_Harten
Auteur
Auteur is patient Ja
Geneesmiddel - primaire code PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 9 dagen, tot en met T, 1 maal per dag 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.6 Medicamenteuze behandeling MBH_300_andermans2[bewerken]

Medicatieafspraak MBH_300_andermans2_MA
Gegevenselement Waarde
Identificatie MBH_300_andermans2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 159 dagen om 08:15 uur
Gebruiksperiode Vanaf T - 159 dagen, gedurende 1 week
Ingangsdatum T - 159 dagen
Gebruiksduur 1 week
Voorschrijver
Zorgverlener Zie Zorgverlener: Jan_van_Harten
Geneesmiddel - primaire code AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 3 maal per dag 1 stuk
MBH identificatie MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_andermans2_TA
Gegevenselement Waarde
Identificatie MBH_300_andermans2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 159 dagen om 09:15 uur
Gebruiksperiode Vanaf T - 159 dagen, gedurende 1 week
Ingangsdatum T - 159 dagen
Gebruiksduur 1 week
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 159 dagen, gedurende 1 week, 3 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 3 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.7 Medicamenteuze behandeling MBH_300_geannuleerd[bewerken]

Medicatieafspraak MBH_300_geannuleerd_MA
Gegevenselement Waarde
Identificatie MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 2 dagen om 18:15 uur
Gebruiksperiode Vanaf T + 5 dagen
Ingangsdatum T + 5 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per dag 1 stuk
MBH identificatie MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_geannuleerd_MA_annuleren
Gegevenselement Waarde
Identificatie MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 1 dag om 15:30 uur
Gebruiksperiode Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur
Ingangsdatum T + 5 dagen
Einddatum T + 5 dagen om 00:00 uur
Medicatieafspraak stop type geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Reden wijzigen of staken medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard ')
Doseerinstructie 2 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_geannuleerd_TA
Gegevenselement Waarde
Identificatie MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 2 dagen om 19:05 uur
Gebruiksperiode Vanaf T + 5 dagen
Ingangsdatum T + 5 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_Jansen_en_Co
Geneesmiddel - primaire code IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 5 dagen, 2 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_geannuleerd_TA_annuleren
Gegevenselement Waarde
Identificatie MBH_300_geannuleerd_TA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 1 dag om 16:45 uur
Gebruiksperiode Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur
Ingangsdatum T + 5 dagen
Einddatum T + 5 dagen om 00:00 uur
Toedieningsafspraak stop type geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_Jansen_en_Co
Toedieningsafspraak reden wijzigen of staken medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur, 2 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.8 Medicamenteuze behandeling MBH_300_toekomstig[bewerken]

Medicatieafspraak MBH_300_toekomstig_MA
Gegevenselement Waarde
Identificatie MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 1 dag om 08:15 uur
Gebruiksperiode Vanaf T + 15 dagen, tot en met T + 51 dagen
Ingangsdatum T + 15 dagen
Einddatum T + 51 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_toekomstig_TA
Gegevenselement Waarde
Identificatie MBH_300_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 1 dag om 09:15 uur
Gebruiksperiode Vanaf T + 15 dagen, tot en met T + 51 dagen
Ingangsdatum T + 15 dagen
Einddatum T + 51 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 15 dagen, tot en met T + 51 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.9 Medicamenteuze behandeling MBH_300_gestoptandermans[bewerken]

Medicatieafspraak MBH_300_gestoptandermans_MA
Gegevenselement Waarde
Identificatie MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 20 dagen om 08:00 uur
Gebruiksperiode Vanaf T - 20 dagen, tot en met T + 7 dagen
Ingangsdatum T - 20 dagen
Einddatum T + 7 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gestoptandermans_MA_staken
Gegevenselement Waarde
Identificatie MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 10 dagen om 18:00 uur
Gebruiksperiode Vanaf T - 20 dagen, tot en met T - 10 dagen
Ingangsdatum T - 20 dagen
Einddatum T - 10 dagen
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Reden wijzigen of staken geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gestoptandermans_TA
Gegevenselement Waarde
Identificatie MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 20 dagen om 09:00 uur
Gebruiksperiode Vanaf T - 20 dagen, tot en met T + 7 dagen
Ingangsdatum T - 20 dagen
Einddatum T + 7 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_Jansen_en_Co
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 20 dagen, tot en met T + 7 dagen, 1 maal per dag 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gestoptandermans_TA_staken
Gegevenselement Waarde
Identificatie MBH_300_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 10 dagen om 19:00 uur
Gebruiksperiode Vanaf T - 20 dagen, tot en met T - 10 dagen
Ingangsdatum T - 20 dagen
Einddatum T - 10 dagen
Toedieningsafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_Jansen_en_Co
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 20 dagen, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.10 Medicamenteuze behandeling MBH_300_gewijzigd_toekomst[bewerken]

Medicatieafspraak MBH_300_gewijzigd_toekomst_MA
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 11 dagen om 08:20 uur
Gebruiksperiode Vanaf T - 11 dagen
Ingangsdatum T - 11 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per week 1 stuk
MBH identificatie MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_wijziging
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 1 dag om 08:10 uur
Gebruiksperiode Vanaf T + 2 dagen
Ingangsdatum T + 2 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Reden wijzigen of staken te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per week 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_techstaken
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 1 dag om 08:10 uur
Gebruiksperiode Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur
Ingangsdatum T - 11 dagen
Einddatum T + 1 dag om 00:00 uur
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Marcha_van_Partners
Geneesmiddel - primaire code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per week 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 11 dagen om 10:30 uur
Gebruiksperiode Vanaf T - 11 dagen
Ingangsdatum T - 11 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 11 dagen, 2 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per week 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_wijziging
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_toekomst_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 1 dag om 11:10 uur
Gebruiksperiode Vanaf T + 2 dagen
Ingangsdatum T + 2 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Toedieningsafspraak reden wijzigen of staken te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 2 dagen, 1 maal per week 1 stuk, Oraal
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 1 maal per week 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie 2.16.840.1.113883.2.4.3.11.999.77.16076005.1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_techstaken
Gegevenselement Waarde
Identificatie MBH_300_gewijzigd_toekomst_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 1 dag om 11:10 uur
Gebruiksperiode Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur
Ingangsdatum T - 11 dagen
Einddatum T + 1 dag om 00:00 uur
Toedieningsafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur, 2 maal per week 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
Doseerinstructie 2 maal per week 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)

1.1.11 Medicamenteuze behandeling MBH_300_gebruik[bewerken]

Medicatiegebruik MBH_300_gebruik_MGB
Gegevenselement Waarde
Identificatie MBH_300_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 1 dag om 08:12 uur
Gebruik indicator Ja
Gebruiksperiode Vanaf T - 10 dagen, tot en met T - 2 dagen
Ingangsdatum T - 10 dagen
Einddatum T - 2 dagen
Auteur
Auteur is patient Ja
Geneesmiddel - Product specificatie
Product naam Paracetamol 500mg
Gebruiksinstructie
Omschrijving Vanaf T - 10 dagen, tot en met T - 2 dagen, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Bouwstenen
Gegevenselement Waarde
Zorgverlener Peter_van_Pulver
Zorgverlener identificatienummer 000001111 (in identificerend systeem: UZI Personen)
Naamgegevens Peter van Pulver
Specialisme Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners
Zorgverlener Marcha_van_Partners
Zorgverlener identificatienummer 000001115 (in identificerend systeem: UZI Personen)
Naamgegevens Marcha van Partners
Specialisme Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Huisartsenpraktijk_Itis
Zorgverlener Jan_van_Harten
Zorgverlener identificatienummer 000002222 (in identificerend systeem: UZI Personen)
Naamgegevens Jan van Harten
Specialisme Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Ziekenhuis_het_Gele_Hart
Zorgaanbieder Apotheek_De_Gulle_Gaper
Zorgaanbieder identificatienummer 01236578 (in identificerend systeem: URA)
Organisatie naam Apotheek De Gulle Gaper
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder identificatienummer 00001111 (in identificerend systeem: URA)
Organisatie naam Huisartsenpraktijk Pulver & Partners
Adresgegevens Werkadres: Dorpsstraat 1 1234AA Ons Dorp
Zorgaanbieder Huisartsenpraktijk_Itis
Zorgaanbieder identificatienummer 00005111 (in identificerend systeem: URA)
Organisatie naam Huisartsenpraktijk Itis
Adresgegevens Werkadres: Langelaan 1 1234ZZ Onze Stad
Zorgaanbieder Apotheek_Jansen_en_Co
Zorgaanbieder identificatienummer 99901111 (in identificerend systeem: URA)
Organisatie naam Apotheek Jansen en Co
Zorgaanbieder Ziekenhuis_het_Gele_Hart
Zorgaanbieder identificatienummer 00004444 (in identificerend systeem: URA)
Organisatie naam Ziekenhuis het Gele Hart
Adresgegevens Werkadres: Groenestraat 1 1200AA Hartstad
Organisatie type Ziekenhuis (code = 'V4' in codeSystem '2.16.840.1.113883.2.4.15.1060')

1.2 Patiënt C. XXX_Dijk[bewerken]

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
Geslachtsnaam
Achternaam XXX_Dijk
Identificatienummer 999900456 [BSN]
Geboortedatum 20 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.2.1 Medicamenteuze behandeling MBH_300_NieuweMA[bewerken]

Medicatieafspraak MBH_300_NieuweMA_start_MA
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 289 dagen om 11:30 uur
Gebruiksperiode Vanaf T - 289 dagen
Ingangsdatum T - 289 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_NieuweMA_stop_MA
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 70 dagen om 13:45 uur
Gebruiksperiode Vanaf T - 289 dagen, tot en met T - 71 dagen
Ingangsdatum T - 289 dagen
Einddatum T - 71 dagen
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Reden wijzigen of staken medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_NieuweMA_nieuw_MA
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 30 dagen om 10:45 uur
Gebruiksperiode Vanaf T - 30 dagen
Ingangsdatum T - 30 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_NieuweMA_start_TA
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 289 dagen om 11:31 uur
Gebruiksperiode Vanaf T - 289 dagen
Ingangsdatum T - 289 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_NieuweMA_stop_TA
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_stop_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 25 dagen om 15:55 uur
Gebruiksperiode Vanaf T - 289 dagen, tot en met T - 71 dagen
Ingangsdatum T - 289 dagen
Einddatum T - 71 dagen
Toedieningsafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Toedieningsafspraak reden wijzigen of staken medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_NieuweMA_nieuw_TA
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 25 dagen om 15:57 uur
Gebruiksperiode Vanaf T - 30 dagen
Ingangsdatum T - 30 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_NieuweMA_start_MGB
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_start_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 289 dagen om 11:32 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 289 dagen
Ingangsdatum T - 289 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1
Relatie medicatieafspraak
Identificatie MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_NieuweMA_nieuw_MGB
Gegevenselement Waarde
Identificatie MBH_300_NieuweMA_nieuw_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 10 dagen om 13:30 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 30 dagen
Ingangsdatum T - 30 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1
Relatie medicatieafspraak
Identificatie MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Bouwstenen
Gegevenselement Waarde
Zorgverlener Peter_van_Pulver
Zorgverlener identificatienummer 000001111 (in identificerend systeem: UZI Personen)
Naamgegevens Peter van Pulver
Specialisme Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder Apotheek_De_Gulle_Gaper
Zorgaanbieder identificatienummer 01236578 (in identificerend systeem: URA)
Organisatie naam Apotheek De Gulle Gaper
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder identificatienummer 00001111 (in identificerend systeem: URA)
Organisatie naam Huisartsenpraktijk Pulver & Partners
Adresgegevens Werkadres: Dorpsstraat 1 1234AA Ons Dorp

1.3 Patiënt C. XXX_Dijk[bewerken]

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
Geslachtsnaam
Achternaam XXX_Dijk
Identificatienummer 999900456 [BSN]
Geboortedatum 20 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.3.1 Medicamenteuze behandeling MBH_300_OTCmedicatie[bewerken]

Medicatieafspraak MBH_300_OTCmedicatie_MA
Gegevenselement Waarde
Identificatie MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 30 dagen om 10:45 uur
Gebruiksperiode Vanaf T - 30 dagen, tot en met T - 16 dagen
Ingangsdatum T - 30 dagen
Einddatum T - 16 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 30 dagen, tot en met T - 16 dagen, 2 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 1 stuk
MBH identificatie MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_OTCmedicatie_TA
Gegevenselement Waarde
Identificatie MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 28 dagen om 14:35 uur
Gebruiksperiode Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur
Ingangsdatum T - 28 dagen
Einddatum T - 14 dagen om 00:00 uur
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur, 2 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud1
Gegevenselement Waarde
Identificatie MBH_300_OTCmedicatie_MGB_oud1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 270 dagen om 16:03 uur
Gebruik indicator Ja
Gebruiksperiode Vanaf T - 280 dagen, tot en met T - 273 dagen
Ingangsdatum T - 280 dagen
Einddatum T - 273 dagen
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 280 dagen, tot en met T - 273 dagen, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud2
Gegevenselement Waarde
Identificatie MBH_300_OTCmedicatie_MGB_oud2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 150 dagen om 11:59 uur
Gebruik indicator Ja
Gebruiksperiode Vanaf T - 155 dagen, tot en met T - 147 dagen
Ingangsdatum T - 155 dagen
Einddatum T - 147 dagen
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 155 dagen, tot en met T - 147 dagen, 3 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 3 maal per dag 1 stuk
MBH identificatie MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud3
Gegevenselement Waarde
Identificatie MBH_300_OTCmedicatie_MGB_oud3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 29 dagen om 09:22 uur
Gebruik indicator Ja
Gebruiksperiode Vanaf T - 80 dagen, tot en met T - 75 dagen
Ingangsdatum T - 80 dagen
Einddatum T - 75 dagen
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 80 dagen, tot en met T - 75 dagen, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_OTCmedicatie_MGB_nieuw
Gegevenselement Waarde
Identificatie MBH_300_OTCmedicatie_MGB_nieuw (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 16 dagen om 14:45 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 28 dagen, tot en met T - 14 dagen
Ingangsdatum T - 28 dagen
Einddatum T - 14 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 28 dagen, tot en met T - 14 dagen, 2 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Bouwstenen
Gegevenselement Waarde
Zorgverlener Peter_van_Pulver
Zorgverlener identificatienummer 000001111 (in identificerend systeem: UZI Personen)
Naamgegevens Peter van Pulver
Specialisme Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder Apotheek_De_Gulle_Gaper
Zorgaanbieder identificatienummer 01236578 (in identificerend systeem: URA)
Organisatie naam Apotheek De Gulle Gaper
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder identificatienummer 00001111 (in identificerend systeem: URA)
Organisatie naam Huisartsenpraktijk Pulver & Partners
Adresgegevens Werkadres: Dorpsstraat 1 1234AA Ons Dorp

1.4 Patiënt C. XXX_Dijk[bewerken]

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
Geslachtsnaam
Achternaam XXX_Dijk
Identificatienummer 999900456 [BSN]
Geboortedatum 20 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.4.1 Medicamenteuze behandeling MBH_300_ToekomstigEnNieuweMA[bewerken]

Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_startMA
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 98 dagen om 15:11 uur
Gebruiksperiode Vanaf T - 98 dagen, gedurende 50 dagen
Ingangsdatum T - 98 dagen
Gebruiksduur 50 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 98 dagen, gedurende 50 dagen, 2 maal per dag 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 2 stuks
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstMA
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 70 dagen om 14:44 uur
Gebruiksperiode Vanaf T + 10 dagen
Ingangsdatum T + 10 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 3 maal per dag 1 stuk
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_stopMA
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 63 dagen om 09:13 uur
Gebruiksperiode Vanaf T - 98 dagen, tot en met T - 63 dagen
Ingangsdatum T - 98 dagen
Einddatum T - 63 dagen
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 98 dagen, tot en met T - 63 dagen, 2 maal per dag 2 stuks, oraal,
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_NieuwMA
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_NieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 63 dagen om 09:15 uur
Gebruiksperiode Vanaf T - 30 dagen, tot en met T + 9 dagen
Ingangsdatum T - 30 dagen
Einddatum T + 9 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Gebruiksinstructie
Omschrijving Vanaf T - 30 dagen, tot en met T + 9 dagen, gedurende 39 dagen 2 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 39 dagen 2 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_startTA
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 98 dagen om 15:15 uur
Gebruiksperiode Vanaf T - 98 dagen
Ingangsdatum T - 98 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstTA
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 70 dagen om 14:45 uur
Gebruiksperiode Vanaf T + 10 dagen
Ingangsdatum T + 10 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 3 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_startMGB
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 98 dagen om 15:20 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 98 dagen
Ingangsdatum T - 98 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 98 dagen, 2 maal per dag 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 2 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_ToekomstMGB
Gegevenselement Waarde
Identificatie MBH_300_ToekomstigEnNieuweMA_ToekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 70 dagen om 14:50 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T + 10 dagen
Ingangsdatum T + 10 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 10 dagen, 3 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 3 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Bouwstenen
Gegevenselement Waarde
Zorgverlener Peter_van_Pulver
Zorgverlener identificatienummer 000001111 (in identificerend systeem: UZI Personen)
Naamgegevens Peter van Pulver
Specialisme Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder Apotheek_De_Gulle_Gaper
Zorgaanbieder identificatienummer 01236578 (in identificerend systeem: URA)
Organisatie naam Apotheek De Gulle Gaper
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder identificatienummer 00001111 (in identificerend systeem: URA)
Organisatie naam Huisartsenpraktijk Pulver & Partners
Adresgegevens Werkadres: Dorpsstraat 1 1234AA Ons Dorp

1.5 Patiënt C. XXX_Dijk[bewerken]

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
Geslachtsnaam
Achternaam XXX_Dijk
Identificatienummer 999900456 [BSN]
Geboortedatum 20 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.5.1 Medicamenteuze behandeling MBH_300_nieuweToekomstigeMA[bewerken]

Medicatieafspraak MBH_300_nieuweToekomstigeMA_startMA
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 20 dagen om 10:01 uur
Gebruiksperiode Vanaf T - 20 dagen, gedurende 3 weken
Ingangsdatum T - 20 dagen
Gebruiksduur 3 weken
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 3 weken 1 maal per dag 1 stuk
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_nieuweToekomstigeMA_toekomstMA
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 15 dagen om 13:26 uur
Gebruiksperiode Vanaf T + 1 dag, gedurende 1 week
Ingangsdatum T + 1 dag
Gebruiksduur 1 week
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 1 week 1 maal per dag 3 stuks
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_nieuweToekomstigeMA_annuleerMA
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_annuleerMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 5 dagen om 15:15 uur
Gebruiksperiode Vanaf T + 1 dag, gedurende 1 week
Ingangsdatum T + 1 dag
Gebruiksduur 1 week
Medicatieafspraak stop type geannuleerd (code = '89925002' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal,
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 1 week 1 maal per dag 3 stuks
Relatie medicatieafspraak
Identificatie MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_nieuweToekomstigeMA_nieuwTMA
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_nieuwTMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 5 dagen om 15:20 uur
Gebruiksperiode Vanaf T + 1 dag, gedurende 4 dagen
Ingangsdatum T + 1 dag
Gebruiksduur 4 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Reden wijzigen of staken foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT')
Geneesmiddel - primaire code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 1 dag, gedurende 4 dagen, gedurende 4 dagen 1 maal per dag 2 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 4 dagen 1 maal per dag 2 stuks
Relatie medicatieafspraak
Identificatie MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_nieuweToekomstigeMA_startTA
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 20 dagen om 10:05 uur
Gebruiksperiode Vanaf T - 20 dagen, gedurende 3 weken
Ingangsdatum T - 20 dagen
Gebruiksduur 3 weken
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 3 weken 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_nieuweToekomstigeMA_toekomstTA
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 15 dagen om 13:30 uur
Gebruiksperiode Vanaf T + 1 dag, gedurende 1 week
Ingangsdatum T + 1 dag
Gebruiksduur 1 week
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 1 week 1 maal per dag 3 stuks
Relatie medicatieafspraak
Identificatie MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_nieuweToekomstigeMA_startMGB
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 20 dagen om 10:10 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 20 dagen, gedurende 3 weken
Ingangsdatum T - 20 dagen
Gebruiksduur 3 weken
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 20 dagen, gedurende 3 weken, gedurende 3 weken 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 3 weken 1 maal per dag 1 stuk
Relatie medicatieafspraak
Identificatie MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_nieuweToekomstigeMA_toekomstMGB
Gegevenselement Waarde
Identificatie MBH_300_nieuweToekomstigeMA_toekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 15 dagen om 13:35 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T + 1 dag, gedurende 1 week
Ingangsdatum T + 1 dag
Gebruiksduur 1 week
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 1 dag, gedurende 1 week, gedurende 1 week 1 maal per dag 3 stuks, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie gedurende 1 week 1 maal per dag 3 stuks
Relatie medicatieafspraak
Identificatie MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Relatie toedieningsafspraak
Identificatie MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Bouwstenen
Gegevenselement Waarde
Zorgverlener Peter_van_Pulver
Zorgverlener identificatienummer 000001111 (in identificerend systeem: UZI Personen)
Naamgegevens Peter van Pulver
Specialisme Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder Apotheek_De_Gulle_Gaper
Zorgaanbieder identificatienummer 01236578 (in identificerend systeem: URA)
Organisatie naam Apotheek De Gulle Gaper
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder identificatienummer 00001111 (in identificerend systeem: URA)
Organisatie naam Huisartsenpraktijk Pulver & Partners
Adresgegevens Werkadres: Dorpsstraat 1 1234AA Ons Dorp

1.6 Patiënt C. XXX_Dijk[bewerken]

Patiënt
Gegevenselement Waarde
Naamgegevens
Initialen C.
Naamgebruik Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
Geslachtsnaam
Achternaam XXX_Dijk
Identificatienummer 999900456 [BSN]
Geboortedatum 20 okt 1963
Geslacht Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')

1.6.1 Medicamenteuze behandeling MBH_300_stopMA_zonder_referentie[bewerken]

Medicatieafspraak MBH_300_stopMA_zonder_referentie_stopMA
Gegevenselement Waarde
Identificatie MBH_300_stopMA_zonder_referentie_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 5 dagen om 13:55 uur
Gebruiksperiode Vanaf T - 14 dagen, tot en met T + 2 dagen
Ingangsdatum T - 14 dagen
Einddatum T + 2 dagen
Medicatieafspraak stop type stopgezet (code = '410546004' in codeSystem 'SNOMED CT')
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, Oraal,
Toedieningsweg Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_stopMA_zonder_referentie_startMA
Gegevenselement Waarde
Identificatie MBH_300_stopMA_zonder_referentie_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 5 dagen om 13:57 uur
Gebruiksperiode Vanaf T - 5 dagen, tot en met T + 2 dagen
Ingangsdatum T - 5 dagen
Einddatum T + 2 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 5 dagen, tot en met T + 2 dagen, 1 maal per dag 1.5 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1.5 stuk
MBH identificatie MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatieafspraak MBH_300_stopMA_zonder_referentie_toekomstMA
Gegevenselement Waarde
Identificatie MBH_300_stopMA_zonder_referentie_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
Medicatieafspraak datum tijd T - 5 dagen om 14:03 uur
Gebruiksperiode Vanaf T + 3 dagen, gedurende 3 dagen
Ingangsdatum T + 3 dagen
Gebruiksduur 3 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T + 3 dagen, gedurende 3 dagen, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Toedieningsafspraak MBH_300_stopMA_zonder_referentie_TA
Gegevenselement Waarde
Identificatie MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
Toedieningsafspraak datum tijd T - 14 dagen om 15:14 uur
Gebruiksperiode Vanaf T - 14 dagen, tot en met T + 2 dagen
Ingangsdatum T - 14 dagen
Einddatum T + 2 dagen
Verstrekker
Zorgaanbieder Zie Zorgaanbieder: Apotheek_De_Gulle_Gaper
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
MBH identificatie MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Medicatiegebruik MBH_300_stopMA_zonder_referentie_MGB
Gegevenselement Waarde
Identificatie MBH_300_stopMA_zonder_referentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
Medicatiegebruik datum tijd T - 14 dagen om 15:20 uur
Gebruik indicator Ja
Volgens afspraak indicator Ja
Gebruiksperiode Vanaf T - 14 dagen, tot en met T + 2 dagen
Ingangsdatum T - 14 dagen
Einddatum T + 2 dagen
Voorschrijver
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Informant
Informant is patient Ja
Auteur
Zorgverlener Zie Zorgverlener: Peter_van_Pulver
Geneesmiddel - primaire code DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
Geneesmiddel - generiekere code DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
Gebruiksinstructie
Omschrijving Vanaf T - 14 dagen, tot en met T + 2 dagen, 1 maal per dag 1 stuk, oraal
Toedieningsweg oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
Doseerinstructie 1 maal per dag 1 stuk
Relatie toedieningsafspraak
Identificatie MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
MBH identificatie MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
Bouwstenen
Gegevenselement Waarde
Zorgverlener Peter_van_Pulver
Zorgverlener identificatienummer 000001111 (in identificerend systeem: UZI Personen)
Naamgegevens Peter van Pulver
Specialisme Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
Zorgaanbieder
Zorgaanbieder Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder Apotheek_De_Gulle_Gaper
Zorgaanbieder identificatienummer 01236578 (in identificerend systeem: URA)
Organisatie naam Apotheek De Gulle Gaper
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners
Zorgaanbieder identificatienummer 00001111 (in identificerend systeem: URA)
Organisatie naam Huisartsenpraktijk Pulver & Partners
Adresgegevens Werkadres: Dorpsstraat 1 1234AA Ons Dorp
Overgenomen van "https://informatiestandaarden.nictiz.nl/index.php?title=mp:VDraft3.0.0_consolidatie_medicatiegegevensMGR_addendum&oldid=177510"